Publicaciones en colaboración con investigadores/as de Hospital Infanta Sofia (16)

2024

  1. Combining loop with thiazide diuretics in patients discharged home after a heart failure decompensation: Association with 30-day outcomes

    European Journal of Internal Medicine, Vol. 127, pp. 126-133

  2. Meta-analysis of genome-wide association studies for cancer therapy-related cardiovascular dysfunction and functional mapping highlight an intergenic region close to TP63

    Scientific Reports, Vol. 14, Núm. 1

  3. Practical tool to identify Spasticity-Plus Syndrome amongst patients with multiple sclerosis. Algorithm development based on a conjoint analysis

    Frontiers in Neurology , Vol. 15

  4. Real-World Evidence of Off-Label Use of Commercially Automated Insulin Delivery Systems Compared to Multiple Daily Insulin Injections in Pregnancies Complicated by Type 1 Diabetes

    Diabetes Technology and Therapeutics, Vol. 26, Núm. 8, pp. 596-606

  5. Real-world safety and effectiveness of dapagliflozin in people living with type 1 diabetes in Spain: The Dapa-ON multicenter retrospective study

    Diabetes and Metabolism, Vol. 50, Núm. 1

  6. The RICA-2 registry: design and baseline characteristics of the first 1,000 patients

    Revista Clinica Espanola, Vol. 224, Núm. 8, pp. 522-533

2023

  1. Autosomal dominant polycystic kidney disease in young adults

    Clinical Kidney Journal, Vol. 16, Núm. 6, pp. 985-995

2022

  1. Benefits of a comprehensive care model in patients with heart failure and preserved ejection fraction: The UMIPIC program

    Revista Clinica Espanola, Vol. 222, Núm. 6, pp. 339-347

  2. Moderate obstructive sleep apnea and cardiovascular outcomes in older adults: a propensity score-matched multicenter study (CPAGE-MODE study)

    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, Vol. 18, Núm. 2, pp. 553-561

2021

  1. Initiation and titration of sacubitril/valsartan in different types of centers

    REC: CardioClinics, Vol. 56, Núm. 2, pp. 92-97

  2. Long-term experience with hyperthermic chemotherapy (Hivec) using mitomycin-c in patients with non-muscle invasive bladder cancer in Spain

    Journal of Clinical Medicine, Vol. 10, Núm. 21

2020

  1. Left Ventricular Ejection Fraction Recovery in Patients with Heart Failure and Reduced Ejection Fraction Treated with Sacubitril/Valsartan

    Cardiology (Switzerland), Vol. 145, Núm. 5, pp. 275-282

2019

  1. Sacubitril/Valsartan in Daily Clinical Practice: Data from a Prospective Registry

    Journal of Cardiovascular Pharmacology, Vol. 73, Núm. 2, pp. 118-124

  2. Sex Influence on the Efficacy and Safety of Sacubitril/Valsartan

    Cardiology (Switzerland), Vol. 142, Núm. 2, pp. 73-78

2018

  1. Clinical Profile of a Nonselected Population Treated With Sacubitril/Valsartan Is Different From PARADIGM-HF Trial

    Journal of cardiovascular pharmacology, Vol. 72, Núm. 2, pp. 112-116

2016

  1. Anti-JC virus seroprevalence in a Spanish multiple sclerosis cohort JC virus seroprevalence in Spain

    Journal of the Neurological Sciences, Vol. 365, pp. 16-21